TABLE 3.
miRNA as diagnostics markers for radiation and immunotherapy.
| MiRNA | Regulation | Therapeutic utility | References |
|---|---|---|---|
| Radiotherapy | |||
| miR-301a, miR-18b, miR-141 | Downregulation | Tolerance to RT marker | Chen et al. (2022a) |
| miR-1323, miR-34c-5p, miR-371a-5p | Upregulation | Tolerance to RT marker | Chen et al. (2022b) |
| miR-200a, miR-93 | Upregulation | Therapy assessment following radiation | Chen et al. (2022a) |
| miR-29b, miR-16, miR-1254, miR-150 | Upregulation | Tolerance to RT marker | Hutchinson et al. (2020) |
| miR-296-5p | Upregulation | Tolerance to RT marker | Maia et al. (2015) |
| Immunotherapy | |||
| Let-7 family | Downregulation | Immunotherapy predictive marker | Yu et al. (2019) |
| miR-28-5p, miR-21-5p, miR-199a-3p | Downregulation | Immunotherapy predictive marker | Li et al. (2018) |
| miR-28-5p, miR-21-5p, miR-200c-3p | Downregulation | Marker of the anti-PD-1/PD-L1 therapy responsiveness | Shukuya et al. (2020) |